MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech & COVID-19

7 Bold Predictions for Medtech After COVID-19

TAGS: Business
<p style="margin:0in 0in 0.0001pt"><strong>The New Normal</strong></p><p style="margin:0in 0in 0.0001pt"> </p><p style="margin:0in 0in 0.0001pt"><span style="font-size:12pt"><span style="font-family:Calibri, sans-serif">Make no mistake about it. The novel coronavirus (COVID-19) is a gamechanger for society going forward. We’re going to be living in a new normal when we (hopefully) move past this. But what that new normal looks like for the medtech and diagnostics industry is a mystery. <em>MD+DI</em>’s managing editor Omar Ford is offering up seven bold predictions about what the industry will look like post-COVID-19.</span></span></p>
What’s going to happen to the industry after the COVID-19 crisis? Some bold predictions about what could happen in medtech and the impact the virus could have on the industry for years to come.
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish